Product Images Prucalopride Succinate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Prucalopride Succinate NDC 70069-822 by Somerset Therapeutics, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Image - ee246af0 b06a 45e2 8efa 704918359d36 01
Image - ee246af0 b06a 45e2 8efa 704918359d36 02
This information is about a medication called Prucalopride in tablet form. The usual dose is one tablet once daily. Each tablet contains Prucaloprid 1.32 mg (equivalent to 1.32 mg of prucalopride succinate). The medication should be kept out of the reach of children and stored at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). It is recommended to store the tablets in the original container to protect them from moisture. The manufacturer of the tablet is Somerset Therapeutics located in Somerset, NJ.*
Image - ee246af0 b06a 45e2 8efa 704918359d36 03
This text provides information about Prucalopride tablets, with each tablet containing 2 mg of Prucalopride (equivalent to 2.64 mg of prucalopride succinate). The usual dose is one tablet once daily. The tablets should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The tablets should be kept out of the reach of children and stored in the original container to protect from moisture. The manufacturer is Somerset Therapeutics, LLC. The package contains 30 tablets with a GTIN code of 00370069822012.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
